Back
Sarepta Therapeutics Vs. Gilead Sciences Industry Stock Comparison
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
128.96
Seasonality Move:
11.13%
Buy
58
GILD
Gilead Sciences
Last Price:
88.25
Seasonality Move:
11.21%
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $88.08. The Score for GILD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.19
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $88.08
The current trend is moderately bullish and GILD is experiencing slight buying pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 58.34 | Buy |
Chaikin Money Flow: | -9031 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.84 - 128.84) | Buy |
Bollinger Bands (100): | (123 - 147.2) | Sell |
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.69 | Buy |
Relative Strength Index (14 RSI): | 63.29 | Buy |
Chaikin Money Flow: | 3176207 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.72 - 87.48) | Buy |
Bollinger Bands (100): | (69.53 - 83.91) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.53 | Buy |
20-day SMA: | 124.83 | Buy |
50-day SMA: | 128.74 | Buy |
200-day SMA: | 130.35 | Sell |
8-day EMA: | 129.2 | Buy |
20-day EMA: | 127.16 | Buy |
50-day EMA: | 128.69 | Buy |
200-day EMA: | 127.96 | Buy |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.88 | Buy |
20-day SMA: | 86.18 | Buy |
50-day SMA: | 82.68 | Buy |
200-day SMA: | 74.14 | Buy |
8-day EMA: | 87.84 | Buy |
20-day EMA: | 86.34 | Buy |
50-day EMA: | 82.91 | Buy |
200-day EMA: | 76.64 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.98 per share, and an increase next year of $3.48 per share.
Sarepta Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gilead Sciences Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |